{
  "ptid_time": "016_S_4902_2014-09-15",
  "img_path": "/data/qiuhui/data/adni/images/016_S_4902/2014-09-15/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 6,118 mm³, 14.0% below the reference mean. With a Z-score of -1.28 (9.9th percentile), this represents mild atrophy; whole brain volume measures 972,928 mm³, 0.2% below the reference mean. With a Z-score of -0.02 (49.1th percentile), this represents normal volume ; entorhinal cortex volume measures 3,294 mm³, 10.3% below the reference mean. With a Z-score of -0.63 (26.3th percentile), this represents normal volume ; fusiform gyrus volume measures 14,262 mm³, 16.2% below the reference mean. With a Z-score of -1.47 (7.1th percentile), this represents mild atrophy; middle temporal gyrus volume measures 18,964 mm³, 1.1% below the reference mean. With a Z-score of -0.09 (46.3th percentile), this represents normal volume . ",
  "text_data": "Age is 77.3 years. Gender is Female. Education: 15 years. MMSE: 23.0. MoCA: 18.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.28 SUVR (moderate elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows mild hippocampal and fusiform gyrus atrophy, along with moderately elevated amyloid (AV45), which are suggestive of early neurodegenerative changes. Cognitive testing (MMSE 23, MoCA 18) indicates mild cognitive impairment, and the presence of one APOE4 allele increases Alzheimer's risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely prodromal Alzheimer’s disease given amyloid positivity and atrophy pattern).  \n\n**Confidence:** **Medium** (clinical and biomarker data align with MCI, but progression to dementia is not yet confirmed).",
  "timestamp": "2025-07-26T00:31:01.882020"
}